EGT Digital will exhibit its latest casino games and full range of iGaming products at SiGMA World 2026, which takes place ...

SpaceX Unifies X Premium, Grok, and Cursor Under a Single 'X Subscription' The bundles start at $8 per month and can go up to ...

Let's rank all 20 Premier League teams again: making sense of Chelsea's poor start, Arsenal's weakness, and whether Hull City ...

XG’s “THE CORE” concerts in Dallas and Mexico City will no longer be taking place. On October 6 KST, XG announced that the Dallas and Mexico City stops of their ongoing “THE CORE” world tour had been ...

Gen X has spent decades getting squeezed between bigger generations. Now, one 38-year-old says the group may have one final trick up its sleeve — disappearing. Realtor Freddie Smith, 38, laid out his ...

Google is rolling out Guided Vision in Gemini Live for blind and low-vision users. Gemini can describe what the camera sees and verbally guide users to reframe the shot when needed. Guided Vision ...

Leavitt, 29, was lounging around in bed with her five-month-old daughter, Viviana, whom she welcomed on May 1 with her husband, Nicholas Riccio, 61, when she accidentally opened a live stream. The ...

After watching the trailer for April X last August, I walked away needing to know: What is Connor Storrie doing in this strange sci-fi movie? The 26-year-old actor is currently riding a wave of fame ...

Meta’s new VR Glasses are what Apple should have created for its Vision Pro line. Also: John Ternus gives Apple employees the week off for Thanksgiving; the company reaches a new agreement with ...

Jeffrey Katzenberg gets much of the credit for overseeing the Disney Renaissance of the late 80s and early 90s, and then in 1994 he became the “K” in “Dreamworks SKG,” and continued his winning streak ...

Two pharmaceutical giants that produce GLP-1 weight-loss drugs are facing lawsuits filed by people who claim their vision loss was caused by the medications. The lawsuits claim Novo Nordisk, the maker ...

Hundreds of consumers are suing the manufacturers of GLP-1 receptor agonists, alleging the medications may increase the risk of a rare form of vision loss. The patients behind the lawsuits allege that ...